Flash FinanceUS
Pre-market S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Prestige Consumer Healthcare (PBH)

Prestige Consumer Healthcare closes $1.045 billion Breathe Right acquisition

Neutral Impact 4 of 5 m&a Written later

Prestige Consumer Healthcare completed its $1.045 billion cash purchase of the Breathe Right brand and certain other brands on June 12, 2026, funded by a new term loan and cash on hand. The company also amended its asset-based revolving credit line, raising commitments to $225 million and extending its maturity five years from the closing date, and the filing describes Breathe Right as becoming Prestige's largest brand.

Key points

  • Purchase price of $1.045 billion in cash for Breathe Right and certain other brands from Foundation Consumer Brands, LLC, closed June 12, 2026
  • New term loan of $1.045 billion priced at Term SOFR plus 2.00%, with quarterly amortization of 0.25% and a possible second draw of up to $95.0 million to help fund the LaCorium Acquisition
  • ABL revolving line commitments increased to $225 million, with maturity extended five years from the closing date

The filing

CompanyPrestige Consumer Healthcare (PBH)
Form8-K, current report
Filed with the SECJun 16, 2026, 6:15 AM ET
Accession number0001104659-26-074259

Items reported: 1.01 Material Definitive Agreement2.01 Acquisition or Disposition Completed2.03 New Direct Financial Obligation8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:55 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 16, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.